Cara Therapeutic Stock Price Prediction
| CARA Stock | USD 0.66 0.03 4.35% |
Oversold Vs Overbought
51
Oversold | Overbought |
Cara Therapeutic stock price prediction is an act of determining the future value of Cara Therapeutic shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Cara Therapeutic's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Cara Therapeutic and does not consider all of the tangible or intangible factors available from Cara Therapeutic's fundamental data. We analyze noise-free headlines and recent hype associated with Cara Therapeutic, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Cara Therapeutic's stock price prediction:EPS Estimate Next Quarter (0.42) | EPS Estimate Current Year (1.09) | EPS Estimate Next Year (1.02) | Wall Street Target Price 5.23 | EPS Estimate Current Quarter (0.41) |
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Cara Therapeutic based on different types of headlines from major news networks to social media. The Cara stock price prediction module provides an analysis of price elasticity to changes in media outlook on Cara Therapeutic over a specific investment horizon. Using Cara Therapeutic hype-based prediction, you can estimate the value of Cara Therapeutic from the perspective of Cara Therapeutic response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Cara Therapeutic using Cara Therapeutic's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Cara using crowd psychology based on the activity and movement of Cara Therapeutic's stock price.
Cara Therapeutic Implied Volatility | 0.0 |
Cara Therapeutic's implied volatility exposes the market's sentiment of Cara Therapeutic stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Cara Therapeutic's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Cara Therapeutic stock will not fluctuate a lot when Cara Therapeutic's options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Cara Therapeutic. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Cara Therapeutic to buy its stock at a price that has no basis in reality. In that case, they are not buying Cara because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Cara Therapeutic after-hype prediction price | USD 0.71 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Cara |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cara Therapeutic's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Cara Therapeutic After-Hype Price Prediction Density Analysis
As far as predicting the price of Cara Therapeutic at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Cara Therapeutic or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Cara Therapeutic, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Cara Therapeutic Estimiated After-Hype Price Volatility
In the context of predicting Cara Therapeutic's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Cara Therapeutic's historical news coverage. Cara Therapeutic's after-hype downside and upside margins for the prediction period are 0.04 and 7.81, respectively. We have considered Cara Therapeutic's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Cara Therapeutic is very risky at this time. Analysis and calculation of next after-hype price of Cara Therapeutic is based on 3 months time horizon.
Cara Therapeutic Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Cara Therapeutic is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Cara Therapeutic backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Cara Therapeutic, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.57 | 7.10 | 0.02 | 0.38 | 6 Events / Month | 5 Events / Month | In about 6 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.66 | 0.71 | 2.90 |
|
Cara Therapeutic Hype Timeline
Cara Therapeutic is currently traded for 0.66. The entity has historical hype elasticity of 0.02, and average elasticity to hype of competition of 0.38. Cara is projected to increase in value after the next headline, with the price projected to jump to 0.71 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is projected to be 2.9%, whereas the daily expected return is currently at 0.57%. The volatility of related hype on Cara Therapeutic is about 1073.05%, with the expected price after the next announcement by competition of 1.04. The company currently holds 43.17 M in liabilities with Debt to Equity (D/E) ratio of 0.01, which may suggest the company is not taking enough advantage from borrowing. Given the investment horizon of 90 days the next projected press release will be in about 6 days. Check out Cara Therapeutic Basic Forecasting Models to cross-verify your projections.Cara Therapeutic Related Hype Analysis
Having access to credible news sources related to Cara Therapeutic's direct competition is more important than ever and may enhance your ability to predict Cara Therapeutic's future price movements. Getting to know how Cara Therapeutic's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Cara Therapeutic may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ALKS | Alkermes Plc | 0.36 | 9 per month | 0.00 | (0.09) | 2.79 | (4.24) | 21.89 | |
| IRWD | Ironwood Pharmaceuticals | 0.31 | 12 per month | 0.00 | (0.10) | 3.82 | (4.53) | 42.91 | |
| DCPH | Deciphera Pharmaceuticals LLC | (0.12) | 10 per month | 2.52 | (0.02) | 4.84 | (4.32) | 17.94 | |
| EGRX | Eagle Pharmaceuticals | (0.40) | 10 per month | 4.87 | 0.03 | 8.00 | (7.92) | 23.10 | |
| NBIX | Neurocrine Biosciences | 4.08 | 10 per month | 1.56 | (0.04) | 2.61 | (2.36) | 8.06 | |
| DVAX | Dynavax Technologies | (0.26) | 9 per month | 0.00 | (0.27) | 2.49 | (2.90) | 6.78 |
Cara Therapeutic Additional Predictive Modules
Most predictive techniques to examine Cara price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Cara using various technical indicators. When you analyze Cara charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Cara Therapeutic Predictive Indicators
The successful prediction of Cara Therapeutic stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Cara Therapeutic, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Cara Therapeutic based on analysis of Cara Therapeutic hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Cara Therapeutic's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Cara Therapeutic's related companies. | 2021 | 2022 | 2023 | 2024 (projected) | Days Sales Outstanding | 18.26 | 38.82 | 69.93 | 66.43 | PTB Ratio | 2.72 | 3.63 | 0.7 | 0.67 |
Story Coverage note for Cara Therapeutic
The number of cover stories for Cara Therapeutic depends on current market conditions and Cara Therapeutic's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Cara Therapeutic is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Cara Therapeutic's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
Cara Therapeutic Short Properties
Cara Therapeutic's future price predictability will typically decrease when Cara Therapeutic's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Cara Therapeutic often depends not only on the future outlook of the potential Cara Therapeutic's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cara Therapeutic's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 54.1 M | |
| Cash And Short Term Investments | 101.2 M |
Check out Cara Therapeutic Basic Forecasting Models to cross-verify your projections. For information on how to trade Cara Stock refer to our How to Trade Cara Stock guide.You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Complementary Tools for Cara Stock analysis
When running Cara Therapeutic's price analysis, check to measure Cara Therapeutic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cara Therapeutic is operating at the current time. Most of Cara Therapeutic's value examination focuses on studying past and present price action to predict the probability of Cara Therapeutic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cara Therapeutic's price. Additionally, you may evaluate how the addition of Cara Therapeutic to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |
Is Cara Therapeutic's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cara Therapeutic. If investors know Cara will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cara Therapeutic listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.19) | Revenue Per Share 0.387 | Quarterly Revenue Growth (0.08) | Return On Assets (0.49) | Return On Equity (1.10) |
The market value of Cara Therapeutic is measured differently than its book value, which is the value of Cara that is recorded on the company's balance sheet. Investors also form their own opinion of Cara Therapeutic's value that differs from its market value or its book value, called intrinsic value, which is Cara Therapeutic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cara Therapeutic's market value can be influenced by many factors that don't directly affect Cara Therapeutic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cara Therapeutic's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cara Therapeutic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cara Therapeutic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.